Site-Specific Nucleic Acid Cleavage Using Metal Nanoparticles

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing nucleic acid strand cleaving methods using silver ions result in low recovery rates due to non-specific interactions, leading to inefficient cleavage and aggregation, while existing site-specific cleavage methods using photodecomposable compounds are cumbersome.

Innovation Solution

Employing metal nanoparticles, particularly silver nanoparticles, as cleaving agents with surface treatment by polyethylene glycol to enhance dispersibility and cleavage efficiency, and using phosphoramidite methods for nucleic acid synthesis to introduce sulfur or selenium sites for targeted cleavage.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If silver ions are used as cleaving agents, then cleavage of nucleic acid strands can be achieved, but the recovery rate of target nucleic acid is low due to non-specific interactions and aggregation

Engineering Contradiction:
Improverecovery rate of target nucleic acidVSAvoidnon-specific interactions and aggregation
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent introduces a specific mediator (cleaving agent with optimized properties) that enables selective cleavage at sulfur or selenium sites without causing non-specific interactions. This mediator approach resolves the contradiction by providing targeted action while avoiding the harmful aggregation effects of conventional silver ions.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes key parameters of the cleving agent system, specifically using metal nanoparticles instead of ionic silver, and controlling particle size and surface properties. These parameter changes maintain cleavage effectiveness while eliminating the non-specific interactions that reduce recovery rate.

Inventive Principle:
Principle #35Parameter changes

2Manufacturing precision

If photodecomposable compounds are used for site-specific cleavage, then cleavage precision is improved, but the process becomes cumbersome

Engineering Contradiction:
Improvesite-specific cleavage precisionVSAvoidprocess complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent replaces complex photodecomposable chemical systems with a simpler nanoparticle-based cleaving system. This substitution maintains site-specific precision through selective binding to sulfur/selenium sites while eliminating the cumbersome photodecomposition requirements and complex reagent handling.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent employs simple, readily available metal nanoparticles as disposable cleaving agents that can be easily introduced and removed, replacing the need for complex, multi-step photodecomposable compound systems. This approach achieves precision without process complexity.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method achieves high cleavage efficiency and recovery rates of target nucleic acids, enabling efficient formation of sticky ends in double-stranded DNA for improved ligation and genetic manipulation processes.

Implementation Method 1

a cleaving step of reacting the nucleic acid to be cleaved with a cleaving agent to cleave the nucleic acid to be cleaved at the part X of the Formula (1)

Methodology Applied
Scientific EffectChemical Bonding: Chemical Bonding

Data Source

PatentEP4410804B1Nucleic acid strand cleaving method, nucleic acid strand cleaving device, double-stranded DNA production method, and double-stranded DNA production device
Publication Date: 2026.02.18 THE JAPAN SCI & TECH AGENCY
  • EP4410804B1 patent drawingFigure 1~3(b)
  • EP4410804B1 patent drawingFigure 4(a)~6
  • EP4410804B1 patent drawingFigure 7(a)~8(b)

AI summary

There is provided a nucleic acid strand cleaving method including a nucleic acid preparation step of preparing a nucleic acid to be cleaved having a structure represented by the following Formula (1), and a cleaving step of reacting the nucleic acid to be cleaved with a cleaving agent to cleave the nucleic acid to be cleaved at the part X of the Formula (1) to generate a nucleic acid having a structure represented by the following Formula (2). The cleaving agent is a metal nanoparticle containing an atom selected from the group consisting of silver, mercury, and cadmium. [Chemical Formula 1] Here, B represents a base, and X represents sulfur or selenium. NucA is composed of at least one nucleotide and is a part of the nucleic acid to be cleaved, and represents a part on the 5' end side with reference to the X. NucB is composed of at least one nucleotide and is a part of the nucleic acid to be cleaved, and represents a part on the 3' end side with reference to the X.